Nova Eye Medical Share Price and Company Fundamentals
Last traded: Today at 2:12 AM
Nova Eye Medical Limited designs, manufactures, distributes, and services medical equipment and devices to diagnose and treat eye diseases. The company offers iTrack, a surgical system for the reduction of intraocular pressure (IOP) in adult patients with openangle glaucoma; and 2RT, a proprietary laser technology to treat patients in early/intermediate age-related macular degeneration. It operates in Australia, the United States, Europe, the Middle East, Japan, rest of Asia, South America, and internationally. Nova Eye Medical Limited was incorporated in 1970 and is headquartered in Kent Town, Australia.
|Primary activities||Medical devices manufacturer.|
|Industry / Sector||Medical Devices / Healthcare|
|Mailing address||107 Rundle Street Kent Town SA 5067 Australia|
|Phone / Fax||/|
|Share registry||COMPUTERSHARE INVESTOR SERVICES PTY LIMITED|
Nova Eye Medical does not pay dividends.
As of May 2021, following are the company executives and directors listed on Nova Eye Medical.
|Mr. Victor Previn B.E., B.Eng||Founder & Exec. Chairman||62||247.38k|
|Ms. Kimberley Menzies||Group Financial Controller & Global Fin. Mang.|
|Mr. Keith Byrne||VP of Global Operations|
|Dr. Thomas Duthy M.B.A., Ph.D.||Head of Investor Relations & Corp. Devel.|
|Ms. Kate Hunt||Head of Marketing|
|Mr. Thomas H. Spurling||Consultant & Director||58|
|Dr. David Lubeck M.D.||Chief Medical Officer|
|Mr. Bill Swaim||Pres of Laserex IS Ellex (USA)|
|Mr. Joaquin V. Wolff||Pres of Ellex iTrack||62|
|Mr. Simon Jeremy Newton Gray C.A., BEc, CA||Company Sec.||61|
Profitability and management effectiveness
Return on assets
Return on equity
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Nova Eye Medical is 45.98M and its enterprise value is 21.12M. The enterprise value to revenue ratio of EYE is 1.66.
The EYE's stocks Beta value is 0.61 making it 39% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
Companies similar to Nova Eye Medical (EYE)
- Ansell (ANN)
- Cochlear (COH)
- Estia Health (EHE)
- Fisher & Paykel Healthcare Corporation (FPH)
- Healius (HLS)
- Nanosonics (NAN)
- Polynovo (PNV)
- Pro Medicus (PME)
- Ramsay Health Care (RHC)
- Resmed Inc (RMD)
- Sonic Healthcare (SHL)
Nova Eye Medical (ASX:EYE) Frequently Asked Questions
1. What is Nova Eye Medical's Stock Symbol?
Nova Eye Medical trades on ASX under the ticker symbol "EYE".
2. What is Nova Eye Medical's stock price today?
One share of EYE stock can currently be purchased for approximately $0.32.
3. How can I contact Nova Eye Medical?
Nova Eye Medical's mailing address is 107 Rundle Street Kent Town SA 5067 Australia. The company can be reached via phone at .
4. What is Nova Eye Medical's official website?
The official website of Nova Eye Medical is http://www.nova-eye.com.
5. Which share registry manages Nova Eye Medical's stock?
Nova Eye Medical's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.